nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Abnormal pigmentation—Epirubicin—liver cancer	0.0287	0.0612	CcSEcCtD
Hydroxychloroquine—Abnormal pigmentation—Doxorubicin—liver cancer	0.0265	0.0566	CcSEcCtD
Hydroxychloroquine—Primaquine—KRT7—liver cancer	0.0236	0.491	CrCbGaD
Hydroxychloroquine—Chloroquine—GSTA2—liver cancer	0.0103	0.215	CrCbGaD
Hydroxychloroquine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0101	0.0215	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Epirubicin—liver cancer	0.00809	0.0173	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Doxorubicin—liver cancer	0.00749	0.016	CcSEcCtD
Hydroxychloroquine—Bullous eruption—Epirubicin—liver cancer	0.00683	0.0146	CcSEcCtD
Hydroxychloroquine—Leukoderma—Epirubicin—liver cancer	0.00635	0.0136	CcSEcCtD
Hydroxychloroquine—Bullous eruption—Doxorubicin—liver cancer	0.00632	0.0135	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Sorafenib—liver cancer	0.00607	0.013	CcSEcCtD
Hydroxychloroquine—Leukoderma—Doxorubicin—liver cancer	0.00588	0.0125	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00562	0.012	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Sorafenib—liver cancer	0.00544	0.0116	CcSEcCtD
Hydroxychloroquine—Cardiomyopathy—Epirubicin—liver cancer	0.00528	0.0113	CcSEcCtD
Hydroxychloroquine—Mood swings—Sorafenib—liver cancer	0.00503	0.0107	CcSEcCtD
Hydroxychloroquine—Cardiomyopathy—Doxorubicin—liver cancer	0.00488	0.0104	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Sorafenib—liver cancer	0.00485	0.0103	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00478	0.0102	CcSEcCtD
Hydroxychloroquine—Eruption—Epirubicin—liver cancer	0.00439	0.00937	CcSEcCtD
Hydroxychloroquine—Primaquine—CYP1A1—liver cancer	0.00431	0.0898	CrCbGaD
Hydroxychloroquine—Psoriasis—Epirubicin—liver cancer	0.0043	0.00917	CcSEcCtD
Hydroxychloroquine—Weight decreased—Sorafenib—liver cancer	0.00415	0.00885	CcSEcCtD
Hydroxychloroquine—Eruption—Doxorubicin—liver cancer	0.00406	0.00867	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00405	0.00865	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Epirubicin—liver cancer	0.004	0.00854	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Epirubicin—liver cancer	0.004	0.00854	CcSEcCtD
Hydroxychloroquine—Psoriasis—Doxorubicin—liver cancer	0.00398	0.00849	CcSEcCtD
Hydroxychloroquine—Paralysis—Epirubicin—liver cancer	0.00389	0.0083	CcSEcCtD
Hydroxychloroquine—Nystagmus—Epirubicin—liver cancer	0.00378	0.00807	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Doxorubicin—liver cancer	0.0037	0.0079	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Doxorubicin—liver cancer	0.0037	0.0079	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Sorafenib—liver cancer	0.00369	0.00787	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Sorafenib—liver cancer	0.00367	0.00783	CcSEcCtD
Hydroxychloroquine—Amodiaquine—CYP1A1—liver cancer	0.00367	0.0763	CrCbGaD
Hydroxychloroquine—Paralysis—Doxorubicin—liver cancer	0.0036	0.00768	CcSEcCtD
Hydroxychloroquine—Scotoma—Epirubicin—liver cancer	0.00356	0.00759	CcSEcCtD
Hydroxychloroquine—Nystagmus—Doxorubicin—liver cancer	0.0035	0.00747	CcSEcCtD
Hydroxychloroquine—Chloroquine—TNF—liver cancer	0.00349	0.0726	CrCbGaD
Hydroxychloroquine—Erythema multiforme—Sorafenib—liver cancer	0.00347	0.00741	CcSEcCtD
Hydroxychloroquine—Tinnitus—Sorafenib—liver cancer	0.00342	0.0073	CcSEcCtD
Hydroxychloroquine—Scotoma—Doxorubicin—liver cancer	0.00329	0.00702	CcSEcCtD
Hydroxychloroquine—Alopecia—Sorafenib—liver cancer	0.00324	0.00692	CcSEcCtD
Hydroxychloroquine—Blood disorder—Epirubicin—liver cancer	0.00323	0.0069	CcSEcCtD
Hydroxychloroquine—Mental disorder—Sorafenib—liver cancer	0.00322	0.00686	CcSEcCtD
Hydroxychloroquine—Malnutrition—Sorafenib—liver cancer	0.0032	0.00682	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Epirubicin—liver cancer	0.00307	0.00656	CcSEcCtD
Hydroxychloroquine—Blood disorder—Doxorubicin—liver cancer	0.00299	0.00639	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Epirubicin—liver cancer	0.00299	0.00638	CcSEcCtD
Hydroxychloroquine—Anaemia—Sorafenib—liver cancer	0.00295	0.0063	CcSEcCtD
Hydroxychloroquine—Angioedema—Sorafenib—liver cancer	0.00292	0.00623	CcSEcCtD
Hydroxychloroquine—Leukopenia—Sorafenib—liver cancer	0.00286	0.0061	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Doxorubicin—liver cancer	0.00284	0.00607	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Sorafenib—liver cancer	0.00281	0.00599	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Doxorubicin—liver cancer	0.00277	0.00591	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0027	0.00577	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Epirubicin—liver cancer	0.0027	0.00577	CcSEcCtD
Hydroxychloroquine—Chloroquine—CYP1A1—liver cancer	0.00265	0.0552	CrCbGaD
Hydroxychloroquine—Nervous system disorder—Sorafenib—liver cancer	0.00256	0.00546	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Sorafenib—liver cancer	0.00255	0.00545	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Epirubicin—liver cancer	0.00254	0.00541	CcSEcCtD
Hydroxychloroquine—Skin disorder—Sorafenib—liver cancer	0.00253	0.00541	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Doxorubicin—liver cancer	0.0025	0.00533	CcSEcCtD
Hydroxychloroquine—Anorexia—Sorafenib—liver cancer	0.00249	0.00531	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Doxorubicin—liver cancer	0.00235	0.00501	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Sorafenib—liver cancer	0.00227	0.00484	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00225	0.00481	CcSEcCtD
Hydroxychloroquine—Fatigue—Sorafenib—liver cancer	0.00225	0.0048	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Epirubicin—liver cancer	0.00224	0.00479	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Epirubicin—liver cancer	0.00223	0.00477	CcSEcCtD
Hydroxychloroquine—Pain—Sorafenib—liver cancer	0.00223	0.00476	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Sorafenib—liver cancer	0.00213	0.00455	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Epirubicin—liver cancer	0.00208	0.00444	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—liver cancer	0.00208	0.00443	CcSEcCtD
Hydroxychloroquine—Urticaria—Sorafenib—liver cancer	0.00207	0.00442	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—liver cancer	0.00207	0.00441	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Sorafenib—liver cancer	0.00206	0.0044	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Sorafenib—liver cancer	0.00206	0.0044	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—liver cancer	0.00205	0.00438	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—liver cancer	0.00201	0.00429	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—liver cancer	0.00201	0.00429	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—liver cancer	0.00193	0.00412	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00192	0.0041	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Sorafenib—liver cancer	0.00192	0.0041	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—liver cancer	0.0019	0.00405	CcSEcCtD
Hydroxychloroquine—Asthenia—Sorafenib—liver cancer	0.00187	0.00399	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—liver cancer	0.00186	0.00397	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—liver cancer	0.00186	0.00397	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—liver cancer	0.00186	0.00396	CcSEcCtD
Hydroxychloroquine—Pruritus—Sorafenib—liver cancer	0.00185	0.00394	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—liver cancer	0.00184	0.00394	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—liver cancer	0.00181	0.00386	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—liver cancer	0.00179	0.00382	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—liver cancer	0.00179	0.00381	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Sorafenib—liver cancer	0.00178	0.00381	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00177	0.00377	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—liver cancer	0.00173	0.00369	CcSEcCtD
Hydroxychloroquine—Dizziness—Sorafenib—liver cancer	0.00172	0.00368	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—liver cancer	0.00172	0.00367	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—liver cancer	0.00171	0.00364	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—liver cancer	0.0017	0.00352	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—liver cancer	0.00169	0.0035	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—liver cancer	0.00169	0.0035	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Epirubicin—liver cancer	0.00168	0.00358	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—liver cancer	0.00168	0.00358	CcSEcCtD
Hydroxychloroquine—Vomiting—Sorafenib—liver cancer	0.00166	0.00354	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—liver cancer	0.00166	0.00354	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—liver cancer	0.00165	0.00341	CbGpPWpGaD
Hydroxychloroquine—Rash—Sorafenib—liver cancer	0.00164	0.00351	CcSEcCtD
Hydroxychloroquine—Dermatitis—Sorafenib—liver cancer	0.00164	0.00351	CcSEcCtD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—liver cancer	0.00163	0.00338	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00163	0.00349	CcSEcCtD
Hydroxychloroquine—Headache—Sorafenib—liver cancer	0.00163	0.00349	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—liver cancer	0.00163	0.00337	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IFT88—liver cancer	0.00163	0.00336	CbGpPWpGaD
Hydroxychloroquine—Pancytopenia—Epirubicin—liver cancer	0.00161	0.00344	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—liver cancer	0.0016	0.00342	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—UGDH—liver cancer	0.00159	0.00329	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—liver cancer	0.00159	0.00329	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—liver cancer	0.00159	0.00329	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—liver cancer	0.00155	0.00322	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Doxorubicin—liver cancer	0.00155	0.00331	CcSEcCtD
Hydroxychloroquine—Nausea—Sorafenib—liver cancer	0.00155	0.00331	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA1—liver cancer	0.00155	0.0032	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—liver cancer	0.00155	0.0033	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—JUN—liver cancer	0.00154	0.00318	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Epirubicin—liver cancer	0.00153	0.00327	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—JUN—liver cancer	0.00152	0.00314	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—liver cancer	0.00151	0.00313	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Epirubicin—liver cancer	0.00151	0.00323	CcSEcCtD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00151	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—liver cancer	0.00151	0.00311	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—liver cancer	0.0015	0.0031	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.0015	0.0032	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—liver cancer	0.00149	0.00318	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—liver cancer	0.00147	0.00305	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—liver cancer	0.00146	0.00302	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—liver cancer	0.00146	0.00302	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—liver cancer	0.00146	0.00301	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK8—liver cancer	0.00145	0.00301	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—liver cancer	0.00144	0.00298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK8—liver cancer	0.00144	0.00298	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00143	0.00305	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—liver cancer	0.00142	0.00303	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—liver cancer	0.00141	0.00301	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—liver cancer	0.0014	0.00289	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Doxorubicin—liver cancer	0.0014	0.00298	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—liver cancer	0.00139	0.00287	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—liver cancer	0.00139	0.00287	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00139	0.00296	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—liver cancer	0.00138	0.00285	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PRKCE—liver cancer	0.00137	0.00283	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—liver cancer	0.00136	0.00282	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Epirubicin—liver cancer	0.00136	0.00291	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—liver cancer	0.00136	0.0029	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—liver cancer	0.00135	0.00279	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—liver cancer	0.00135	0.00279	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—liver cancer	0.00134	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—liver cancer	0.00134	0.00277	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—liver cancer	0.00134	0.00277	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—liver cancer	0.00133	0.00275	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—liver cancer	0.00133	0.00275	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—liver cancer	0.00132	0.00273	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Epirubicin—liver cancer	0.00131	0.00279	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—liver cancer	0.0013	0.00278	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ABL1—liver cancer	0.0013	0.0027	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—liver cancer	0.00129	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—liver cancer	0.00129	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—liver cancer	0.00129	0.00267	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Epirubicin—liver cancer	0.00128	0.00274	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—liver cancer	0.00127	0.00271	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—liver cancer	0.00126	0.0027	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—liver cancer	0.00126	0.00269	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—liver cancer	0.00126	0.00268	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA1—liver cancer	0.00122	0.00253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—liver cancer	0.00121	0.00251	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Doxorubicin—liver cancer	0.00121	0.00258	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—liver cancer	0.0012	0.00256	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—liver cancer	0.00119	0.00246	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Epirubicin—liver cancer	0.00119	0.00254	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—liver cancer	0.00119	0.00253	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—liver cancer	0.00118	0.00252	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00118	0.00243	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—liver cancer	0.00118	0.00243	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Doxorubicin—liver cancer	0.00117	0.0025	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—liver cancer	0.00117	0.0025	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—liver cancer	0.00116	0.0024	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00116	0.0024	CbGpPWpGaD
Hydroxychloroquine—Tension—Epirubicin—liver cancer	0.00116	0.00247	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—liver cancer	0.00115	0.00238	CbGpPWpGaD
Hydroxychloroquine—Nervousness—Epirubicin—liver cancer	0.00115	0.00245	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—liver cancer	0.00112	0.00232	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Epirubicin—liver cancer	0.00111	0.00238	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—liver cancer	0.00111	0.00237	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—liver cancer	0.0011	0.00235	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—liver cancer	0.0011	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ADAM17—liver cancer	0.0011	0.00227	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Doxorubicin—liver cancer	0.00109	0.00233	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—liver cancer	0.00109	0.00233	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—liver cancer	0.00109	0.00232	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—liver cancer	0.00108	0.00224	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PRKCE—liver cancer	0.00108	0.00224	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—liver cancer	0.00107	0.00222	CbGpPWpGaD
Hydroxychloroquine—Tension—Doxorubicin—liver cancer	0.00107	0.00229	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—liver cancer	0.00106	0.00226	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—liver cancer	0.00106	0.00226	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—liver cancer	0.00106	0.00226	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—liver cancer	0.00105	0.00217	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Epirubicin—liver cancer	0.00104	0.00222	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2L1—liver cancer	0.00104	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ABL1—liver cancer	0.00103	0.00213	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Doxorubicin—liver cancer	0.00103	0.0022	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PSMA4—liver cancer	0.00103	0.00213	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PSMD10—liver cancer	0.00103	0.00213	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Epirubicin—liver cancer	0.00102	0.00218	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—liver cancer	0.00101	0.00216	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—liver cancer	0.001	0.00214	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000998	0.00213	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SHC3—liver cancer	0.000997	0.00206	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Doxorubicin—liver cancer	0.000982	0.0021	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK14—liver cancer	0.000981	0.00203	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Doxorubicin—liver cancer	0.000978	0.00209	CcSEcCtD
Hydroxychloroquine—Oedema—Epirubicin—liver cancer	0.000964	0.00206	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—liver cancer	0.00096	0.00205	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000953	0.00197	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Doxorubicin—liver cancer	0.000947	0.00202	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—liver cancer	0.000945	0.00202	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—liver cancer	0.000944	0.00201	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—liver cancer	0.000936	0.002	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.000929	0.00192	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—liver cancer	0.000929	0.00192	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000924	0.00197	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—liver cancer	0.000919	0.00196	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—liver cancer	0.000918	0.0019	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000914	0.00189	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNA1—liver cancer	0.000902	0.00187	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000901	0.00186	CbGpPWpGaD
Hydroxychloroquine—Oedema—Doxorubicin—liver cancer	0.000892	0.0019	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—liver cancer	0.000875	0.00187	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—liver cancer	0.000873	0.00186	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—liver cancer	0.000866	0.00185	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ADAM17—liver cancer	0.000866	0.00179	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—liver cancer	0.000857	0.00177	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Epirubicin—liver cancer	0.000857	0.00183	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—liver cancer	0.00085	0.00181	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000845	0.00175	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—liver cancer	0.000838	0.00179	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000836	0.00173	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000834	0.00172	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000832	0.00178	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—liver cancer	0.000831	0.00177	CcSEcCtD
Hydroxychloroquine—Pain—Epirubicin—liver cancer	0.000824	0.00176	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000824	0.0017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2L1—liver cancer	0.000819	0.0017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000814	0.00168	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSMA4—liver cancer	0.000814	0.00168	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSMD10—liver cancer	0.000814	0.00168	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CD—liver cancer	0.0008	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PRKCE—liver cancer	0.000798	0.00165	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—liver cancer	0.000793	0.00169	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—liver cancer	0.000788	0.00168	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000786	0.00163	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000777	0.00161	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK14—liver cancer	0.000776	0.0016	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Doxorubicin—liver cancer	0.000775	0.00165	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FST—liver cancer	0.000774	0.0016	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00077	0.00164	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—liver cancer	0.000769	0.00164	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000766	0.00158	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Epirubicin—liver cancer	0.000766	0.00163	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—liver cancer	0.000763	0.00163	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—liver cancer	0.000762	0.00163	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—liver cancer	0.000762	0.00163	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ABL1—liver cancer	0.000759	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TRIO—liver cancer	0.000738	0.00153	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000729	0.00156	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—RAF1—liver cancer	0.000714	0.00148	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HGF—liver cancer	0.000714	0.00148	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNA1—liver cancer	0.000713	0.00147	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—liver cancer	0.00071	0.00152	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—liver cancer	0.000708	0.00151	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR4—liver cancer	0.000708	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—liver cancer	0.000706	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CSF2—liver cancer	0.000706	0.00146	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Doxorubicin—liver cancer	0.000705	0.0015	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—liver cancer	0.000705	0.0015	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CB—liver cancer	0.000697	0.00144	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MTOR—liver cancer	0.000697	0.00144	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—liver cancer	0.000692	0.00148	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000685	0.00142	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—liver cancer	0.000682	0.00146	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Epirubicin—liver cancer	0.000659	0.00141	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—liver cancer	0.000657	0.0014	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1B—liver cancer	0.000654	0.00135	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000651	0.00135	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—liver cancer	0.00064	0.00137	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—liver cancer	0.000637	0.00136	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CD—liver cancer	0.000632	0.00131	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—liver cancer	0.000631	0.00135	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PRKCE—liver cancer	0.000631	0.0013	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—JUN—liver cancer	0.000623	0.00129	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000621	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—liver cancer	0.000618	0.00128	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—liver cancer	0.000613	0.00131	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—liver cancer	0.00061	0.0013	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—liver cancer	0.000608	0.0013	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—liver cancer	0.000607	0.0013	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—liver cancer	0.000604	0.00129	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1A—liver cancer	0.000604	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2L1—liver cancer	0.000604	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ABL1—liver cancer	0.0006	0.00124	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—liver cancer	0.00059	0.00126	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK8—liver cancer	0.000589	0.00122	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—liver cancer	0.000573	0.00122	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—MAPK14—liver cancer	0.000571	0.00118	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—liver cancer	0.000567	0.00121	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RAF1—liver cancer	0.000564	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HGF—liver cancer	0.000564	0.00117	CbGpPWpGaD
Hydroxychloroquine—Rash—Doxorubicin—liver cancer	0.000562	0.0012	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—liver cancer	0.000562	0.0012	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ADAM17—liver cancer	0.00056	0.00116	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—liver cancer	0.000559	0.00119	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD8A—liver cancer	0.000558	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CSF2—liver cancer	0.000558	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CB—liver cancer	0.000551	0.00114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MTOR—liver cancer	0.000551	0.00114	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—liver cancer	0.00053	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PSMA4—liver cancer	0.000526	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PSMD10—liver cancer	0.000526	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1B—liver cancer	0.000517	0.00107	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000506	0.00105	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000499	0.00103	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—JUN—liver cancer	0.000492	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—liver cancer	0.000489	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDH1—liver cancer	0.000488	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1A—liver cancer	0.000477	0.000987	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2L1—liver cancer	0.000477	0.000987	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—liver cancer	0.000466	0.000964	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK8—liver cancer	0.000466	0.000964	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000465	0.000962	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—liver cancer	0.000463	0.000957	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK14—liver cancer	0.000452	0.000934	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—liver cancer	0.000425	0.000879	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000417	0.000864	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAF1—liver cancer	0.000416	0.00086	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000412	0.000852	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRKCE—liver cancer	0.000408	0.000843	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MTOR—liver cancer	0.000406	0.00084	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—liver cancer	0.000406	0.00084	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—liver cancer	0.000393	0.000813	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF2—liver cancer	0.000386	0.000799	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—liver cancer	0.000385	0.000797	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000384	0.000794	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—liver cancer	0.000381	0.000788	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000378	0.000783	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—liver cancer	0.000376	0.000778	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—liver cancer	0.000373	0.000771	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—liver cancer	0.000368	0.000762	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—liver cancer	0.000366	0.000756	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000364	0.000752	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—JUN—liver cancer	0.000363	0.00075	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CSF2—liver cancer	0.000361	0.000746	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—liver cancer	0.00036	0.000745	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000359	0.000742	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—H2AFX—liver cancer	0.000355	0.000735	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—liver cancer	0.000352	0.000727	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—liver cancer	0.000347	0.000718	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK8—liver cancer	0.000343	0.00071	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—liver cancer	0.000336	0.000695	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RAF1—liver cancer	0.000329	0.00068	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—liver cancer	0.000321	0.000665	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MTOR—liver cancer	0.000321	0.000664	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—liver cancer	0.000321	0.000664	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—liver cancer	0.000314	0.000649	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—liver cancer	0.000311	0.000643	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—liver cancer	0.000301	0.000623	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—liver cancer	0.000297	0.000615	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—liver cancer	0.000295	0.00061	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—liver cancer	0.000294	0.000608	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK14—liver cancer	0.000292	0.000604	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JUN—liver cancer	0.000287	0.000593	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—liver cancer	0.000286	0.000593	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—liver cancer	0.000285	0.000589	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—F2—liver cancer	0.000283	0.000585	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—liver cancer	0.000278	0.000575	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—liver cancer	0.000274	0.000568	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UGDH—liver cancer	0.000272	0.000563	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK8—liver cancer	0.000271	0.000561	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—liver cancer	0.000271	0.00056	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—liver cancer	0.000271	0.00056	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—liver cancer	0.000269	0.000557	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EPT1—liver cancer	0.000256	0.000529	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—liver cancer	0.000255	0.000527	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—liver cancer	0.000248	0.000513	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—liver cancer	0.000248	0.000512	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TAT—liver cancer	0.000242	0.000502	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—liver cancer	0.000238	0.000493	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—liver cancer	0.000235	0.000487	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—liver cancer	0.000229	0.000474	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—liver cancer	0.000219	0.000453	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—liver cancer	0.000213	0.000441	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RAF1—liver cancer	0.000213	0.00044	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—liver cancer	0.000208	0.000429	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTOR—liver cancer	0.000208	0.000429	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—liver cancer	0.000202	0.000418	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—liver cancer	0.000196	0.000405	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—liver cancer	0.000195	0.000403	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—liver cancer	0.000191	0.000395	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—liver cancer	0.000191	0.000394	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—liver cancer	0.000186	0.000384	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—liver cancer	0.000185	0.000384	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—liver cancer	0.000184	0.000381	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—liver cancer	0.000181	0.000374	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—liver cancer	0.00018	0.000373	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—liver cancer	0.00018	0.000372	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK8—liver cancer	0.000175	0.000363	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—liver cancer	0.000173	0.000358	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CPT1B—liver cancer	0.000165	0.000341	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GLUL—liver cancer	0.000165	0.000341	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—liver cancer	0.000162	0.000335	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—liver cancer	0.00016	0.000332	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—liver cancer	0.00016	0.000331	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NR1H4—liver cancer	0.000159	0.000329	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA3—liver cancer	0.000156	0.000323	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—liver cancer	0.000149	0.000308	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—liver cancer	0.000149	0.000308	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA4—liver cancer	0.000143	0.000296	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA2—liver cancer	0.000139	0.000288	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—liver cancer	0.000138	0.000285	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA1—liver cancer	0.000134	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAT2—liver cancer	0.000133	0.000275	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDOB—liver cancer	0.000127	0.000263	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—liver cancer	0.000126	0.000262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—liver cancer	0.000122	0.000253	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CRABP1—liver cancer	0.000122	0.000251	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—liver cancer	0.000117	0.000242	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—liver cancer	0.000112	0.000232	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPGDS—liver cancer	0.000106	0.00022	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—liver cancer	0.000103	0.000214	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSMA4—liver cancer	9.47e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSMD10—liver cancer	9.47e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GOT2—liver cancer	9.21e-05	0.00019	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2E1—liver cancer	8.66e-05	0.000179	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYCS—liver cancer	8.1e-05	0.000168	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GOT1—liver cancer	7.95e-05	0.000164	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GGT1—liver cancer	7.95e-05	0.000164	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—liver cancer	7.14e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMOX1—liver cancer	7.04e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—liver cancer	6.56e-05	0.000136	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—liver cancer	6.22e-05	0.000129	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—liver cancer	5.8e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARA—liver cancer	5.69e-05	0.000118	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.87e-05	0.000101	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—liver cancer	4.7e-05	9.73e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.28e-05	8.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—liver cancer	4.23e-05	8.75e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.73e-05	7.72e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.28e-05	4.71e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—liver cancer	1.86e-05	3.85e-05	CbGpPWpGaD
